Roche Holding AG (RHHBY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
| Previous close | 30.91 |
| Open | 31.47 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 31.23 - 31.59 |
| 52-week range | 29.95 - 40.48 |
| Volume | |
| Avg. volume | 2,621,690 |
| Market cap | 201.863B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 15.86 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.39 (4.51%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- Zacks
Roche (RHHBY) Alecensa Wins FDA Nod for Label Expansion
Roche (RHHBY) has won FDA approval for Alecensa as an adjuvant treatment, following tumor resection for patients with ALK-positive non-small cell lung cancer.
- Zacks
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.
- Zacks
Adaptimmune (ADAP) Down on End of Collaboration With Roche
Adaptimmune's (ADAP) shares plummet as the company;s collaboration to develop and commercialize allogeneic cell therapies with Roche gets terminated.
© 2024 Yahoo. All rights reserved.